 |
Journal articles
Predictors of long-term drug survival for infliximab in psoriasis
Q. Magis
D. Jullien
C. Gaudy-Marqueste
K. Baumstark
M. Viguier
1
H. Bachelez
F. Guibal
E. Delaporte
E. Karimova
H. Montaudié
T. Boye
F. Aubin
M. Beylot-Barry
M.-A. Richard
M. Beylot-Barry
Author
M.-A. Richard
Author
1
IRMAIC - Immuno-Régulation dans les Maladies Auto-Immunes Inflammatoires et le Cancer - EA 7509 (Université de Reims Champagne-Ardenne
Pôle Santé
Bâtiment Recherche
51 rue Cognacq-Jay
51095 Reims Cedex - France)
- URCA - Université de Reims Champagne-Ardenne : EA 7509 (2 avenue Robert Schuman, 51100 Reims. - France)
Document type :
Journal articles
Domain :
Complete list of metadata
https://hal.univ-reims.fr/hal-03605001
Contributor : Arnaud Pommier Connect in order to contact the contributor
Submitted on : Thursday, March 10, 2022 - 5:21:14 PM
Last modification on : Friday, March 11, 2022 - 3:12:36 AM
Contributor : Arnaud Pommier Connect in order to contact the contributor
Submitted on : Thursday, March 10, 2022 - 5:21:14 PM
Last modification on : Friday, March 11, 2022 - 3:12:36 AM
Identifiers
- HAL Id : hal-03605001, version 1
- DOI : 10.1111/jdv.13747
Citation
Q. Magis, D. Jullien, C. Gaudy-Marqueste, K. Baumstark, M. Viguier, et al.. Predictors of long-term drug survival for infliximab in psoriasis. Journal of the European Academy of Dermatology and Venereology, Wiley, 2017, 31 (1), pp.96-101. ⟨10.1111/jdv.13747⟩. ⟨hal-03605001⟩
Metrics
Record views